| Ytd | 25.59% | |
| 1y | 100.76% |
| Open | 2.55 | Prev Close | 2.57 | Low | 2.52 | High | 2.67 | Mkt Cap | 191.64M |
| Vol | 890.16K | Avg Vol | 468.51K | EPS | -1.64 | P/E | N/A | Forward P/E | -1.17 |
| Beta | 0.04 | Short Ratio | 6.61 | Inst. Own | 78.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 2.62 | 200-d Avg | 2.49 | 1yr Est | 10.80 |
Acumen Pharmaceuticals, Inc. (ABOS) Analyst/Investor Day Transcript
BTIG analyst Thomas Shrader reiterates Acumen Pharmaceuticals (NASDAQ:ABOS) with a Buy and mainta